Lexicon Pharma (LXRX) Tops Q4 EPS by 3c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.31 -1.28%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $26.55 million versus the consensus estimate of $7.16 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Home Federal Bancorp of Louisiana (HFBL) Tops Q2 EPS by 46c
- enVVeno Medical (NVNO) Misses Q2 EPS by 537c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
